Deletion of tumor suppressor genes in Chinese non-small cell lung cancer

被引:28
作者
An, Q
Liu, Y
Gao, YN
Huang, JF
Fong, XL
Liu, LY
Zhang, DC
Zhang, JJ
Cheng, SJ [1 ]
机构
[1] Peking Union Med Coll, Canc Inst Hosp, Dept Chem Etiol & Carcinogenesis, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Beijing 100021, Peoples R China
[3] Third Mil Med Univ, Prevent Med Coll, Hyg Toxicol Dept, Chongqing 400038, Peoples R China
关键词
loss of heterozygosity; tumor suppressor gene; squamous cell carcinoma; adenocarcinoma; lung cancer;
D O I
10.1016/S0304-3835(02)00204-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study, we used 22 microsatellite markers flanking to or within 13 known or candidate tumor suppressor genes (TSGs) to detect loss of heterozygosity (LOH) in these chromosomal regions among 41 cases of non-small cell lung cancer, including 28 squamous cell carcinoma (SCC) and 13 adenocarcinoma (ADC). The studied TSGs comprised FHIT, VHL, APC, PRLTS, p16, IFNA, PTEN, p57, ATM, p53, BRCA1, DPC4 and DCC. Our data demonstrated frequent allelic losses of FHIT, p53, IFNA, VHL and p16 in both SCC and ADC. PTEN and ATM showed the least frequency of LOH, while no deletion of BRCA1 was detected in all tumor samples. LOH analysis of PRLTS was extended to 26 cases of ADC, which demonstrated significantly higher frequency of LOH than SCC. Our data indicated a possible correlation between specific TSG(s) and either histological type of lung cancer, and more attention should be paid to the PRLTS gene, which might play an important role in the development of ADC. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 48 条
[21]  
2-T
[22]   Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors [J].
Masood, R ;
Cai, J ;
Zheng, T ;
Smith, DL ;
Hinton, DR ;
Gill, PS .
BLOOD, 2001, 98 (06) :1904-1913
[23]  
Nagatake M, 1996, CANCER RES, V56, P2718
[24]   Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p [J].
Petersen, I ;
Langreck, H ;
Wolf, G ;
Schwendel, A ;
Psille, R ;
Vogt, P ;
Reichel, MB ;
Ried, T ;
Diefel, M .
BRITISH JOURNAL OF CANCER, 1997, 75 (01) :79-86
[25]  
Petersen S, 2000, BRIT J CANCER, V82, P65
[26]  
Reed AL, 1996, CANCER RES, V56, P3630
[27]   PRESENCE OF ELEVATED LEVELS OF PLATELET-DERIVED GROWTH-FACTOR (PDGF) IN LUNG ADENOCARCINOMA PLEURAL EFFUSIONS [J].
SAFI, A ;
SADMI, M ;
MARTINET, N ;
MENARD, O ;
VAILLANT, P ;
GALLATI, H ;
HOSANG, M ;
MARTINET, Y .
CHEST, 1992, 102 (01) :204-207
[28]  
Salvesen HB, 2001, INT J CANCER, V91, P22, DOI 10.1002/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO
[29]  
2-S
[30]   Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer [J].
Sato, K ;
Tamura, G ;
Tsuchiya, T ;
Endoh, Y ;
Usuba, O ;
Kimura, W ;
Motoyama, T .
BRITISH JOURNAL OF CANCER, 2001, 85 (02) :199-203